Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Science Translational Medicine|November 4, 2011
ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin toleranceLihan Sun, Julio Cesar Batista Ferreira, Daria Mochly-RosenFrontiers in Bioscience (Scholar Edition)|December 29, 2011
Regulation of cardiac excitability by protein kinase C isozymesJulio Cesar Batista Ferreira, Daria Mochly-Rosen, Mohamed BoutjdirJournal of Molecular and Cellular Cardiology|November 2, 2010
βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failureJulio Cesar Batista Ferreira, Patricia Chakur Brum, Daria Mochly-RosenComparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|June 26, 2023
Commentary: Aldehyde dehydrogenase, redox balance and exercise physiology: What is missing?Wagner Ribeiro Pereira, Julio Cesar Batista Ferreira, Guilherme Giannini ArtioliCardiovascular Research|January 27, 2009
Protein kinase C in heart failure: a therapeutic target?Suresh Selvaraj Palaniyandi, Lihan Sun, Julio Cesar Batista Ferreira, et al.Physiological Reviews|January 3, 2014
Targeting aldehyde dehydrogenase 2: new therapeutic opportunitiesChe-Hong Chen, Julio Cesar Batista Ferreira, Eric R Gross, et al.Journal of Cellular and Molecular Medicine|September 30, 2010
PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responsesSuresh Selvaraj Palaniyandi, Julio Cesar Batista Ferreira, Patricia Chakur Brum, et al.Drug Discovery Today. Disease Mechanisms|February 1, 2011
Regulation of mitochondrial processes: a target for heart failureSuresh Selvaraj Palaniyandi, Xin Qi, Gouri Yogalingam, et al.Antioxidants & Redox Signaling|January 19, 2022
Mitochondrial Fusion, Fission, and Mitophagy in Cardiac Diseases: Challenges and Therapeutic OpportunitiesDébora da Luz Scheffer, Adriana Ann Garcia, Lucia Lee, et al.Pageof 3